These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

883 related articles for article (PubMed ID: 33068096)

  • 1. Cotrimoxazole Induced Steven Johnson Syndrome: A Case Report.
    Acharya A; Acharya SP; Bhattarai TR
    JNMA J Nepal Med Assoc; 2020 Sep; 58(229):702-704. PubMed ID: 33068096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry.
    Diphoorn J; Cazzaniga S; Gamba C; Schroeder J; Citterio A; Rivolta AL; Vighi GD; Naldi L;
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):196-203. PubMed ID: 26687641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetaminophen induced Steven Johnson syndrome-toxic epidermal necrolysis overlap.
    Khawaja A; Shahab A; Hussain SA
    J Pak Med Assoc; 2012 May; 62(5):524-7. PubMed ID: 22755330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trimethoprim-sulfamethoxazole-induced Stevens-Johnson syndrome: a case report.
    Langlois MR; Derk F; Belczyk R; Zgonis T
    J Am Podiatr Med Assoc; 2010; 100(4):299-303. PubMed ID: 20660883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
    Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
    Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trimethoprim-sulfamethoxazole-induced Steven Johnson syndrome in an HIV-infected patient.
    Taqi SA; Zaki SA; Nilofer AR; Sami LB
    Indian J Pharmacol; 2012; 44(4):533-5. PubMed ID: 23087524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pristinamycin-induced toxic epidermal necrolysis: A case report.
    Ouni B; Mansour K; Slim R; Abdessayed N; Bensayed N; Barka M; Fathallah N
    Br J Clin Pharmacol; 2024 Aug; 90(8):1869-1872. PubMed ID: 36394376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steven Johnson Syndrome and Toxic Epidermal Necrolysis in a burn unit: A 15-year experience.
    McCullough M; Burg M; Lin E; Peng D; Garner W
    Burns; 2017 Feb; 43(1):200-205. PubMed ID: 27554629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis.
    Baltazard T; Dhaille F; Duvert-Lehembre S; Lok C; Chaby G
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Roujeau JC; Kelly JP; Naldi L; Rzany B; Stern RS; Anderson T; Auquier A; Bastuji-Garin S; Correia O; Locati F
    N Engl J Med; 1995 Dec; 333(24):1600-7. PubMed ID: 7477195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of toxic epidermal necrolysis by a multidisciplinary team. A review of literature and treatment results.
    Papp A; Sikora S; Evans M; Song D; Kirchhof M; Miliszewski M; Dutz J
    Burns; 2018 Jun; 44(4):807-815. PubMed ID: 29627131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute generalized exanthematous pustulosis and Stevens-Johnson syndrome overlap due to hydroxychloroquine: a case report.
    Coleman I; Ruiz G; Brahmbhatt S; Ackerman L
    J Med Case Rep; 2020 Nov; 14(1):210. PubMed ID: 33138853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pattern of cutaneous drug eruption among children and adolescents in north India.
    Sharma VK; Dhar S
    Pediatr Dermatol; 1995 Jun; 12(2):178-83. PubMed ID: 7659648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse drug reactions and organ damage: The skin.
    Marzano AV; Borghi A; Cugno M
    Eur J Intern Med; 2016 Mar; 28():17-24. PubMed ID: 26674736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous artifactual disease represented as recurrent toxic epidermal necrolysis.
    Gowring LE; Johnson R; Hivnor CM; Henning JS
    Cutis; 2016 Sep; 98(3):E6-E7. PubMed ID: 27814420
    [No Abstract]   [Full Text] [Related]  

  • 18. Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective descriptive study.
    Carrasquillo OY; Santiago-Vazquez M; Cardona R; Cruz-Manzano M; Figueroa LD
    Int J Dermatol; 2019 Nov; 58(11):1293-1299. PubMed ID: 31166019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole.
    Rijal JP; Pompa T; Giri S; Bhatt VR
    BMJ Case Rep; 2014 Jul; 2014():. PubMed ID: 25008332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced Lyell and Stevens-Johnson syndromes.
    Prescrire Int; 2009 Feb; 18(99):20-2. PubMed ID: 19391288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.